October 17, 2019
  • October 17, 2019
Breaking News

Tag Archives

Global Blood Therapeutics, Inc. (NASDAQ:GBT) Stock Slumped 6.05% in Pre-market

by on June 26, 2019 0
Global Blood Therapeutics, Inc. (NASDAQ:GBT) announced an agreement to sell approximately $200.0 million in shares of its common stock in a registered underwritten public offering.  In addition, GBT has granted the underwriter a 30-day option to purchase up to approximately $30.0 million in shares of its common stock. Global Blood Therapeutics, Inc. (NASDAQ:GBT) shares fell -1.36%... Read More